Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.

  • STATUS
    Recruiting
  • End date
    Feb 17, 2022
  • participants needed
    1800
  • sponsor
    Bayer
Updated on 8 September 2021
Investigator
Bayer Clinical Trials Contact
Primary Contact
H pital Purpan - Toulouse (0.0 mi away) Contact
+261 other location

Summary

The purpose of this study is to try to find the best dose of the new drug BAY 2433334 to give to participants and to look at how well BAY 2433334 works on top of antiplatelet therapy in patients following a recent non cardioembolic ischemic stroke which occurs when a blood clot that has not formed in the heart travelled to the brain. BAY 2433334, works by blocking a step of the blood clotting process in our body and thins the blood and is a so called oral FXIa inhibitor.

Details
Condition Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke
Treatment BAY2433334, BAY2433334 matching placebo
Clinical Study IdentifierNCT04304508
SponsorBayer
Last Modified on8 September 2021

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note